Status and Problems of Adverse Event Reporting Systems in Korean Hospitals [PDF]
Healthcare Informatics Research, 2010 ObjectivesThis study identifies the current status and problems of adverse event reporting system in Korean hospitals. The data obtained from this study will be used to raise international awareness and enable collaborative researches on patient safety ...
Jeongeun Kim +3 more
doaj +9 more sources
Indications and adverse events of teriparatide: based on FDA adverse event reporting system (FAERS) [PDF]
Frontiers in PharmacologyBackgroundTeriparatide is approved for osteoporosis. Post-marketing surveillance is critical given its widespread use.ObjectiveTo investigate adverse events (AEs) associated with teriparatide using the FAERS database, compare association strengths for ...
Ming-Tao Wen +11 more
doaj +3 more sources
Adverse event reporting systems and safer healthcare [PDF]
Quality and Safety in Health Care, 2009 At the heart of improvement and safety in healthcare is the now-familiar tenet that was espoused decades ago by Demming and paraphrased by Berwick.1 Need we repeat it again? Every defect should lead to improvement processes that make care safer. It is time to deliver on the promise of reporting systems in patient safety.
James B Battles, David Stevens
openalex +5 more sources
Military Healthcare Providers Reporting of Adverse Events Following Immunizations to the Vaccine Adverse Event Reporting System [PDF]
Military Medicine, 2014 We studied military health care provider (HCP) practices regarding reporting of adverse events following immunization (AEFI).A convenience sample of HCP was surveyed to assess familiarity with Vaccine Adverse Event Reporting System (VAERS), AEFI they were likely to report, methods used and preferred for reporting, and perceived barriers to reporting ...
Rongxia Li +7 more
openalex +3 more sources
Assessing taxane-associated adverse events using the FDA adverse event reporting system database
Chinese Medical Journal, 2021 . Background:. Taxanes are an essential class of antineoplastic agents used to treat various cancers and are a fundamental cause of hypersensitivity reactions. In addition, other adverse events, such as bone marrow toxicity and peripheral neuropathy, can
Dong-Hui Lao +4 more
doaj +3 more sources
Comparison of the adverse event profiles of conventional and liposomal formulations of doxorubicin using the FDA adverse event reporting system. [PDF]
PLoS ONE, 2017 Doxorubicin (DOX) is an anthracycline widely used for the treatment of solid and hematological tumors. The aim of this study was to assess the adverse event profiles of conventional DOX and liposomal DOX. This is the first study to evaluate the effect of
Akiho Fukuda +12 more
doaj +3 more sources
Adverse event profile of lorazepam: a real-world pharmacovigilance study using the FDA adverse event reporting system database [PDF]
Frontiers in PharmacologyIntroductionAnxiety diagnoses have surged recently during and after the COVID-19 pandemic. Lorazepam is widely recognized for its efficacy in treatment of anxiety, as well as insomnia, etc.
Zhengkang Su +4 more
doaj +2 more sources
Ophthalmic corticosteroids-related adverse events: the FDA adverse event reporting system (FAERS) database pharmacovigilance study [PDF]
Frontiers in PharmacologyBackgroundCorticosteroids are extensively used in ophthalmology, particularly for treating various inflammatory conditions. Despite their effectiveness, prolonged or high-dose corticosteroid use is associated with significant adverse drug reactions (ADRs)
Chengzhi Liu, Xinyu Wang, Xusheng Cao
doaj +2 more sources
Age-stratified analysis of adverse event signals for clarithromycin: a disproportionality analysis using the FDA Adverse Event Reporting System [PDF]
Therapeutic Advances in Drug SafetyBackground: Clarithromycin is a widely used antibiotic, but its safety profile, particularly in different age groups, remains inadequately explored. Objectives: This study aims to characterize and illustrate the features of clarithromycin-related adverse
Haiyan Mai +4 more
doaj +2 more sources
Disproportionality analysis of reslizumab based on the FDA Adverse Event Reporting System [PDF]
Therapeutic Advances in Drug SafetyBackground: With the increasing prescription of reslizumab for severe asthma with an eosinophilic phenotype, a real-world pharmacovigilance analysis of reslizumab is urgently required to detect potential unreported adverse events (AEs) in clinical ...
Huqun Li, Cuilian Guo, Chongshu Wang
doaj +2 more sources